Published in Cephalalgia on February 01, 2010
Comments on results of Scher et al. pertaining to nonprescription caffeine-containing combination analgesics. Cephalalgia (2010) 1.38
Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999-2010. J Gen Intern Med (2015) 1.35
Management of primary chronic headache in the general population: the Akershus study of chronic headache. J Headache Pain (2011) 1.15
Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain (2012) 0.99
Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics? BMC Neurol (2011) 0.85
Medication-overuse headache: a review. J Pain Res (2014) 0.85
Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse. Eur J Clin Pharmacol (2015) 0.84
Study protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care. BMC Neurol (2012) 0.82
Use of a fixed combination of acetylsalicylic acid, acetaminophen and caffeine compared with acetaminophen alone in episodic tension-type headache: meta-analysis of four randomized, double-blind, placebo-controlled, crossover studies. J Headache Pain (2014) 0.80
Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf (2014) 0.79
A new mutation in GFAP widens the spectrum of Alexander disease. Eur J Hum Genet (2014) 0.79
Opioid-induced central immune signaling: implications for opioid analgesia. Headache (2015) 0.79
Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol (2016) 0.78
Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: Implications for extracranial origin of headache. Ann Neurol (2016) 0.78
Chronic morphine increases Fos-positive neurons after concurrent cornea and tail stimulation. Headache (2011) 0.75
Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain (2016) 0.75
Medication-overuse headache: a perspective review. Ther Adv Drug Saf (2016) 0.75
[The role of opioids in the treatment of primary headache disorders]. Schmerz (2014) 0.75
Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache (2001) 6.93
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61
Migraine prevalence, disease burden, and the need for preventive therapy. Neurology (2007) 6.57
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA (1992) 4.77
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia (2010) 4.24
Screening for dementia with the memory impairment screen. Neurology (1999) 3.92
Clinical and prognostic subforms of new daily-persistent headache. Neurology (2010) 3.60
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia (2010) 3.54
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology (1996) 3.15
Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA (2000) 3.07
Burden of migraine in the United States: disability and economic costs. Arch Intern Med (1999) 3.05
A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med (2000) 2.90
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia (2003) 2.87
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84
Prevalence of frequent headache in a population sample. Headache (2004) 2.82
Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain (2003) 2.79
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78
Migraine diagnosis and treatment: results from the American Migraine Study II. Headache (2001) 2.74
Epidemiology of tension-type headache. JAMA (1998) 2.63
Memory impairment on free and cued selective reminding predicts dementia. Neurology (2000) 2.58
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry (2010) 2.57
Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology (2006) 2.51
Migraine and cardiovascular disease: a population-based study. Neurology (2010) 2.51
Migraine in the United States: epidemiology and patterns of health care use. Neurology (2002) 2.49
Migraine in adolescents: association with socioeconomic status and family history. Neurology (2007) 2.46
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology (2001) 2.43
Global prevalence of chronic migraine: a systematic review. Cephalalgia (2010) 2.43
Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain (2000) 2.41
The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35
A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology (2005) 2.34
Low blood pressure and the risk of dementia in very old individuals. Neurology (2003) 2.30
Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol (1999) 2.30
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29
Hemicrania continua: ten new cases and a review of the literature. Neurology (1994) 2.26
A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry (1988) 2.21
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia (2010) 2.18
A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain (1997) 2.16
Memory and mental status correlates of modified Braak staging. Neurobiol Aging (2000) 2.15
Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology (2003) 2.14
Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology (2000) 2.08
Migraine, quality of life, and depression: a population-based case-control study. Neurology (2000) 2.06
Medical consultation for migraine: results from the American Migraine Study. Headache (1998) 1.99
Headache and major depression: is the association specific to migraine? Neurology (2000) 1.91
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology (1999) 1.89
Education delays accelerated decline on a memory test in persons who develop dementia. Neurology (2007) 1.87
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia (2008) 1.83
Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia (1999) 1.82
Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med (2001) 1.82
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther (2000) 1.76
Phase I clinical and pharmacokinetic study of taxol. Cancer Res (1987) 1.74
Cumulative lifetime migraine incidence in women and men. Cephalalgia (2008) 1.73
The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J Gerontol B Psychol Sci Soc Sci (1996) 1.73
Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol (1993) 1.70
Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology (1999) 1.70
Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68
Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology (2011) 1.67
Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis (2012) 1.66
Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology (2008) 1.66
Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology (2007) 1.64
Pediatric migraine and the International Headache Society (IHS) criteria. Neurology (1997) 1.63
Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Arch Neurol (1998) 1.60
Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache (1994) 1.59
A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology (1998) 1.57
Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology (2011) 1.57
An epidemiologic study of headache among adolescents and young adults. JAMA (1989) 1.57
Patterns of health care utilization for migraine in England and in the United States. Neurology (2003) 1.57
Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia (2010) 1.56
A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology (2006) 1.54
Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology (2001) 1.53
Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology (2009) 1.51
Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci (2000) 1.50
Questionnaires for collecting detailed occupational information for community-based case control studies. Am Ind Hyg Assoc J (1998) 1.47
Comorbidity of migraine and epilepsy. Neurology (1994) 1.46
Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol (2001) 1.46
Miscarriages among female physical therapists who report using radio- and microwave-frequency electromagnetic radiation. Am J Epidemiol (1993) 1.44
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol (1987) 1.44
Apoplectic headache and oculomotor nerve palsy: an unusual presentation of multiple sclerosis. Neurology (1990) 1.43
Seronegative chronic relapsing neuroborreliosis. Eur Neurol (1995) 1.43
Variation in migraine prevalence by race. Neurology (1996) 1.42
Hemicrania continua: attacks may alternate sides. Headache (1992) 1.41
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia (1993) 1.41
Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev (1995) 1.41
Dystonia related to cocaine withdrawal: a case report and pathogenic hypothesis. Neurology (1989) 1.39
Measuring work organization exposure over the life course with a job-exposure matrix. Scand J Work Environ Health (1993) 1.39